Carregant...

First-in-child use of the oral soluble guanylate cyclase stimulator riociguat in pulmonary arterial hypertension

Riociguat has been approved for use in adults with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension. No clinical data on its therapeutic use in children with PAH are currently available. We report the case of a now four-year-old boy who initially presented at th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pulm Circ
Autors principals: Spreemann, Till, Bertram, Harald, Happel, Christoph M., Kozlik-Feldmann, Rainer, Hansmann, Georg
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2017
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5731721/
https://ncbi.nlm.nih.gov/pubmed/29099661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045893217743123
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!